• Study of gemtuzumab ozogamicin and chemotherapy combinations in children with newly diagnosed acute myeloid leukemia, high-risk myelodysplastic syndrome, or myeloid sarcoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Ireland

  • Study on Risankizumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Drugs:
    Czechia Hungary Lithuania Poland

  • Study of Isatuximab with drug combination for newly diagnosed multiple myeloma patients with severe kidney problems

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Greece

  • Study on the Safety and Effects of Belantamab Mafodotin with Lenalidomide and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Greece

  • Study of Atezolizumab, Carboplatin, and Paclitaxel for Elderly Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on the Safety and Effectiveness of Pitolisant for Children Aged 6-17 with Narcolepsy, with or without Cataplexy

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy

  • Study on the Safety and Effectiveness of PF-07104091 Alone or with Fulvestrant, Letrozole, and Palbociclib for Patients with Advanced Breast, Ovarian, or Lung Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria

  • Study on Chemotherapy with Irinotecan, Folinic Acid, Fluorouracil, Oxaliplatin, and Floxuridine for Patients with Colorectal Cancer Spread to the Liver

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on the Effectiveness of Autologous Stem Cell Transplantation with Cytarabine in Patients with Aggressive Multiple Sclerosis

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Italy

  • Study on the Effectiveness and Safety of Taplucainium Inhalation Powder (NOC-110) for Adults with Refractory or Unexplained Chronic Cough

    Not recruiting

    2 1
    Investigated Drugs:
    Belgium Germany Poland

powered by